TSB Regenerative Medicine Calls go live

The two Technology Strategy Board regenerative medicine competitions, which we anticipate last month, have now gone live.

A link to the Developing Therapeutics competition may be found here.

A link to the Tools & Technologies competition may be found here.  

To discuss this matter further, contact Julian Hitchcock
 
The Epigenetic Advance: CellCentric Licences Novel Discovery Programme to Takeda

CellCentric, the world-leading epigenetics company based in Cambridge UK, has announced details of a significant deal, which takes epigenetic science closer towards clinical application and commercialisation in the field of cancer.  The company has a considerable IP resource in novel epigenetic targets.  It is from this portfolio that CellCentric has granted to Takeda Pharmaceutical Company Limited an exclusive licence to develop a key cancer programme. More details here.
 
  • EESCN Sponsors
  • EESCN Sponsors
Follow CamStem on Twitter

Upcoming events

<<  March 2010  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
  1  2  3  4  5  6  7
  8  91011121314
15161718192021
22232425262728
293031    

© 2010 East of England Stem Cell Network | Disclaimer and Privacy Policy